EXOZEXOZYMES INC.
- Market cap
- $37.22M
- as of 2026-10-23
- Latest close
- $4.00
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-11-18
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Rayo Edgardo Javier | Oct 1 | Oct 19 | A · derivative | 25,000 | $6.28 | $157,000 | 25,000 | No | Form 4 |
| Marlett Christopher A | Oct 1 | Oct 19 | A · derivative | 10,000 | $6.28 | $62,800 | 10,000 | No | Form 4 |
| Lalonde James Joseph | Oct 1 | Oct 19 | A · derivative | 10,000 | $6.28 | $62,800 | 10,000 | No | Form 4 |
| Digiandomenico Anthony | Oct 1 | Oct 19 | A · derivative | 10,000 | $6.28 | $62,800 | 10,000 | No | Form 4 |
| Bowie James Ulrich | Oct 1 | Oct 19 | A · derivative | 10,000 | $6.28 | $62,800 | 10,000 | No | Form 4 |
| Bell Lon E | Oct 1 | Oct 19 | A · derivative | 10,000 | $6.28 | $62,800 | 10,000 | No | Form 4 |
| Nawaz FouadVice President- Finance | Sep 14 | Sep 17 | A · derivative | 45,000 | $6.28 | $282,600 | 45,000 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Aug 26 | Sep 2 | P | 4 | $7.58 | Purchase +$30 | 14,708 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Aug 26 | Sep 2 | P | 251 | $7.35 | Purchase +$1,845 | 14,704 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Aug 26 | Sep 2 | P | 250 | $7.60 | Purchase +$1,900 | 14,453 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Aug 25 | Sep 2 | P | 250 | $7.52 | Purchase +$1,880 | 14,203 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Aug 25 | Sep 2 | P | 100 | $7.50 | Purchase +$750 | 13,953 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Aug 19 | Sep 2 | A | 8,841 | $6.40 | $56,582 | 13,853 | No | Form 4 |
| Korman Tyler PazChief Scientific Officer | Aug 19 | Aug 25 | M | 32,964 | not reported | not reported | 762,837 | No | Form 4 |
| Korman Tyler PazChief Scientific Officer | Aug 19 | Aug 25 | M · derivative | 32,964 | $0.00 | $0 | 46,140 | No | Form 4 |
| Perriman Damien AlanChief Commercial Officer | Aug 19 | Aug 25 | M | 19,612 | not reported | not reported | 28,499 | No | Form 4 |
| Perriman Damien AlanChief Commercial Officer | Aug 19 | Aug 25 | M · derivative | 19,612 | $0.00 | $0 | 43,147 | No | Form 4 |
| Korman Tyler PazChief Scientific Officer | Apr 9 | Apr 10 | S | 750 | $10.53 | Sale −$7,898 | 729,123 | No | Form 4 |
| Korman Tyler PazChief Scientific Officer | Apr 8 | Apr 10 | S | 750 | $10.04 | Sale −$7,530 | 729,873 | No | Form 4 |
| Korman Tyler PazChief Scientific Officer | Apr 1 | Apr 8 | A | 5,332 | $8.44 | $45,002 | 730,623 | No | Form 4 |
| Nawaz FouadVice President- Finance | Apr 1 | Apr 8 | A | 5,999 | $8.44 | $50,632 | 9,488 | No | Form 4 |
| Opgenorth Paul HideoVice President, Development | Apr 1 | Apr 8 | A | 3,999 | $8.44 | $33,752 | 645,149 | No | Form 4 |
| Perriman Damien AlanChief Commercial Officer | Apr 1 | Apr 8 | A | 8,887 | $8.44 | $75,006 | not reported | No | Form 4 |
| Perriman Damien AlanChief Commercial Officer | Apr 1 | Apr 8 | A | 62,759 | $0.00 | $0 | 62,759 | No | Form 4 |
| Perriman Damien AlanChief Commercial Officer | Apr 1 | Apr 8 | A · derivative | 146,437 | $9.49 | $1,389,687 | 146,437 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Jul 2, 2025 | Jul 2, 2025 | P | 1,040 | $10.22 | Purchase +$10,629 | 10,628.8 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Jun 17, 2025 | Jun 20, 2025 | A · derivative | 235,817 | $12.40 | $2,924,131 | 235,817 | No | Form 4 |
| Korman Tyler PazVice President, Research | Jun 16, 2025 | Jun 17, 2025 | A | 2,990 | $12.54 | $37,495 | 725,291 | No | Form 4 |
| Nawaz FouadVice President, Finance | Jun 13, 2025 | Jun 17, 2025 | A | 3,489 | $12.54 | $43,752 | 3,489 | No | Form 4 |
| Opgenorth Paul HideoVice President, Development | Jun 13, 2025 | Jun 17, 2025 | A | 2,990 | $12.54 | $37,495 | 641,150 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Jan 17, 2025 | Jan 21, 2025 | P | 1,767 | $10.78 | Purchase +$19,048 | 3,872 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Jan 16, 2025 | Jan 21, 2025 | P | 121 | $10.72 | Purchase +$1,297 | 2,105 | No | Form 4 |
| Heltzen MichaelChief Executive Officer | Nov 15, 2024 | Nov 19, 2024 | P | 1,984 | $11.10 | Purchase +$22,022 | 1,984 | No | Form 4 |
| MDB Capital Holdings, LLC | Nov 8, 2024 | Nov 18, 2024 | C | 122,657 | $6.40 | $785,005 | 3,931,133 | No | Form 4 |
| Opgenorth Paul HideoVice President, Development | Nov 8, 2024 | Nov 18, 2024 | C | 2,344 | $6.40 | $15,002 | 640,504 | No | Form 4 |